Search for: "Novo Nordisk, Inc." Results 1 - 20 of 138
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Sep 2017, 4:33 am by Gregory J. Brod
Department of Justice (DOJ) announced pharmaceutical manufacturer Novo Nordisk Inc. has agreed to pay $58.65 million for failing to comply with a Food and Drug Administration (FDA) mandated Risk Evaluation and Mitigation Strategy (REMS) program. [read post]
27 Jul 2011, 4:06 pm by Lawrence B. Ebert
The panel invited a response from Plaintiffs-Appellants Novo Nordisk A/S and Novo Nordisk, Inc. [read post]
5 Apr 2012, 8:27 pm
District Court for the Southern District of New York against Novo Nordisk, Inc., a Danish pharmaceuticals company. [read post]
21 Aug 2011, 9:16 pm by Patent Docs
• Defendants: Novo Nordisk, Inc.; Novo Nordisk A/S Declaratory judgment of invalidity, unenforceability, and non-infringement of U.S. [read post]
30 Jan 2009, 9:58 pm
Novo Nordisk will retain such rights in North America. [read post]
10 Jun 2011, 7:11 am by Ben Vernia
According to DOJ’s press release: Novo Nordisk Inc., a Danish pharmaceutical manufacturer, has agreed to pay $25 million to resolve its civil liability arising from the illegal promotion of its hemostasis management drug, NovoSeven, the Justice Department announced today. [read post]
17 Mar 2011, 11:28 am by Morse, Barnes-Brown Pendleton
Food and Drug Administration on the company’s V-Go Disposable Insulin Delivery Device for use with Novo Nordisk’s NovoLog® for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing [...] [read post]